Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00983749 · ClinicalTrials.gov registry record · Phase 1
Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke
A Phase 1 study of Stroke, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
- 3
- Study locations
NCT00983749 is a Phase 1 study of Stroke that has completed, run by University of California, San Diego. The registered enrollment target is 23 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT00983749, a Phase 1 study of Stroke, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine if external counterpulsation (ECP) is feasible to perform, tolerable, and safe as a treatment for patients with acute ischemic stroke (i.e., a blockage of one of the arteries supplying a part of the brain), and to assess what type of effect it might have on 1) the velocity of blood flow in the arteries supplying the brain and 2) stroke symptoms. The hypothesis of the study is that ECP will be feasible and safe to perform, and will be tolerable for patients with acute ischemic stroke at pressures that increase the velocity of arterial blood flow to the brain.
Conditions Studied
Interventions
- DEVICE Full-pressure ECP
- DEVICE Sham-pressure ECP
Study Locations (3)
California
- UCLA Medical Center - Los Angeles
- UCSD Medical Center - San Diego
Alabama
- University of Alabama Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00983749
The ClinicalTrials.gov registry entry for NCT00983749 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Full-pressure ECP is the first listed.
NCT00983749 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Alabama.
Frequently Asked Questions
What is clinical trial NCT00983749 about?
NCT00983749 is a clinical study titled "Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke". The purpose of this study is to determine if external counterpulsation (ECP) is feasible to perform, tolerable, and safe as a treatment for patients with acute ischemic stroke (i.e., a blockage of one of the arteries supplying a part of the brain), and to assess what type of effect it might have on ...
What is the current status of trial NCT00983749?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2009-12. Estimated completion is 2013-07.
What conditions does trial NCT00983749 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT00983749?
The interventions under investigation include: Full-pressure ECP (DEVICE), Sham-pressure ECP (DEVICE).
Who is sponsoring clinical trial NCT00983749?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00983749 being conducted?
This trial has 3 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
Hybrid Robot+FES Stroke Rehabilitation
RECRUITING · Phase 1
-
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
RECRUITING · Phase 1
-
Facilitating Neuroplastic Changes of Acute Stroke Survivors
RECRUITING · Phase 1
-
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
RECRUITING · Phase 1
-
Accelerated rTMS vs. Sham for Stroke Apathy
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.